Moreover, the abnormal expression of miR-224 up-regulated glycogen synthase kinase 3 beta (GSK-3β), inhibited Wnt/β-catenin signal pathway and reduced adramycin (ADM) resistance to CRC [53]. Here, GSK3B is linked to colorectal carcinoma.